Home

MAX LINK

CIK 1050944 · last filed 2014-08-14

MAX LINK is a corporate insider who has filed 75 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for AMDA, was dated Aug 14, 2014. Across all open-market trades the lifetime net is +$755.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $19.6K across reported positions. 38 SEC filings were submitted jointly with ALEXION PHARMACEUTICALS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$19.6K

Companies

8

Total Filings

75

Lifetime Open-Market Net

$755.8K

Filer Profile

Reported Address
509 MADISON AVE 14TH FL
NEW YORK, NY 10022
Related Filers
ALEXION PHARMACEUTICALS, INC. — 38 joint filings, latest 2014-05-07
CYTRX CORP — 15 joint filings, latest 2013-12-12
PDL BIOPHARMA, INC. — 13 joint filings, latest 2006-12-22
COLUMBIA LABORATORIES INC — 2 joint filings, latest 2004-05-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sintx Technologies, Inc. (AMDA) Delisted Director 5,138 — — $0 2 2014-08-14
BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted Director — — — $0 1 2014-08-05
Imunon, Inc. (CLSN) Delisted Director 25,359 $1.96 $49.7K $571.6K 18 2014-02-12
LadRx Corp (CYTXW) Delisted Director 260,305 — — $65.9K 7 2013-12-12
DSCO Director 794 $24.64 $19.6K $0 1 2012-06-12
LadRx Corp (CYTR) Delisted Director 804 — — $0 3 2008-07-09
Imunon, Inc. (CLN) Delisted Director 113,362 — — $118.4K 6 2008-05-05
HUMAN GENOME SCIENCES INC (HGSI) Delisted Director 27,699 — — $0 5 2008-04-14

Recent Filings

75 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-08-14 Sintx Technologies, Inc. (AMDA) Delisted Grant (A) +6,984 $0 EDGAR
2014-08-05 BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted Grant (A) — $0 EDGAR
2014-03-04 — Grant (A) +895 $0
2014-02-21 Sintx Technologies, Inc. (AMDA) Delisted Conv (C) +57,864 $0 EDGAR
2014-02-12 Imunon, Inc. (CLSN) Delisted Grant (A) — $0 EDGAR
2014-02-05 — Sell (S) −40,000 -$6.21M
2013-12-12 LadRx Corp (CYTXW) Delisted Grant (A) — $0 EDGAR
2013-05-09 — Grant (A) — $0
2013-05-08 Imunon, Inc. (CLSN) Delisted Grant (A) — $0 EDGAR
2013-02-08 — Grant (A) +2,471 $0
Showing 1–10 of 75
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.